Modulation of basal and morphine-induced neuronal activity by a NPFF 2 selective agonist measured by c-Fos mapping of the mouse brain

Synapse

Volumn 64, Issue 9, 2010, Pages 672-681

  Moulédous, Lionel ^a,b   Frances, Bernard ^c   Zajac, Jean Marie ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Université Paul Sabatier   (France)

Author keywords

Immediate early gene; Neuropeptide FF; Nucleus accumbens; Opioid; Reward; Stress

Indexed keywords

DEXTRO ASPARAGINYLPROLYL (N METHYL)ALANYLPHENYLALANYLLEUCYLPHENYLALANYLGLYCYLPROLYLGLYCYLARGINYLPHENYLALANIN AMIDE; MORPHINE; NEUROPEPTIDE FF; NEUROPEPTIDE FF 2; OPIATE RECEPTOR; PEPTIDE; PROTEIN C FOS; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE FF RECEPTOR; NEUROPEPTIDE RECEPTOR;

ADOLESCENT; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; FEMALE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; LIMBIC CORTEX; LOW DRUG DOSE; MOUSE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PREOPTIC AREA; PRIORITY JOURNAL; REWARD; SENSITIZATION; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS; AGONISTS; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; BRAIN LEVEL; C57BL MOUSE; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM;

ANALGESICS, OPIOID; ANIMALS; BRAIN; BRAIN CHEMISTRY; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED C57BL; MORPHINE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, NEUROPEPTIDE;

EID: 77956461992     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20774     Document Type: Article

References (44)

1. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yao WJ, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B. 2000. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275:39324-39331.
2. Caille S, Parsons LH. 2006. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway. Neuropsychopharmacology 31:804-813.
3. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP. 2007. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: Implications for the integration of limbic inputs. J Neurosci 27:2025-2034.
4. Di Chiara G, Bassareo V. 2007. Reward system and addiction: What dopamine does and doesn't do. Curr Opin Pharmacol 7:69-76.
5. Ducret E, Anderson GM, Herbison AE. 2009. RFamide-related peptide-3, a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone neuron firing in the mouse. Endocrinology 150:2799-2804.
6. Dupouy V, Zajac JM. 1995. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul Pept 59:349-356.
7. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM. 2000. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275:25965-25971.
8. Feldman S, Conforti N, Saphier D. 1990. The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion. Neuroscience 37:775-779. (Pubitemid 20282215)
9. Garcia MM, Brown HE, Harlan RE. 1995. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res 692:23-40.
10. Gelot A, Frances B, Gicquel S, Zajac JM. 1998. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Eur J Pharmacol 358:203-206.
11. Gouarderes C, Jhamandas K, Sutak M, Zajac JM. 1996. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br J Pharmacol 117:493-501.
12. Gouarderes C, Puget A, Zajac JM. 2004. Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: A comparative autoradiographic study. Synapse 51:249-269.
13. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y, Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M. 2000. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2:703-708.
14. Jhamandas JH, Mactavish D. 2002. Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and up-regulation of NPFF gene expression in the rat brainstem. J Comp Neurol 447:300-307. (Pubitemid 34461457)
15. Jhamandas JH, MacTavish D. 2003. Central administration of neuropeptide FF causes activation of oxytocin paraventricular hypothalamic neurones that project to the brainstem. J Neuroendocrinol 15:24-32.
16. Jhamandas JH, MacTavish D, Harris KH. 2006. Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN). Peptides 27:973-979.
17. Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. 2003. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res 987:122-125.
18. Kavaliers M. 1990. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci Lett 115:307-312. (Pubitemid 20231632)
19. Koob GF. 2008. A role for brain stress systems in addiction. Neuron 59:11-34.
20. Koob GF, Volkow ND. 2010. Neurocircuitry of Addiction. Neuropsychopharmacology 35:217-238.
21. Kotani M, Mollereau C, Detheux M, Le Poul E, Brezillon S, Vakili J, Mazarguil H, Vassart G, Zajac JM, Parmentier M. 2001. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 133:138-144.
22. Kotlinska J, Pachuta A, Dylag T, Silberring J. 2007a. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Peptides 28:2235-2242.
23. Kotlinska J, Pachuta A, Dylag T, Silberring J. 2007b. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Neuropeptides 41:51-58.
24. Kovacs KJ. 1998. c-Fos as a transcription factor: A stressful (re)view from a functional map. Neurochem Int 33:287-297.
25. Lake JR, Hammond MV, Shaddox RC, Hunsicker LM, Yang HY, Malin DH. 1991. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132:29-32.
26. Marchand S, Betourne A, Marty V, Daumas S, Halley H, Lassalle JM, Zajac JM, Frances B. 2006. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 27:964-972.
27. Marco N, Stinus L, Allard M, Le Moal M, Simonnet G. 1995. Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: Localization and functional antiopioid involvement. Neuroscience 64:1035-1044.
28. Mazarguil H, Gouarderes C, Tafani JA, Marcus D, Kotani M, Mollereau C, Roumy M, Zajac JM. 2001. Structure-activity relationships of neuropeptide FF: Role of C-terminal regions. Peptides 22:1471-1478.
29. Mickiewicz AL, Dallimore JE, Napier TC. 2009. The ventral pallidum is critically involved in the development and expression of morphine-induced sensitization. Neuropsychopharmacology 34:874-886.
30. Oberling P, Stinus L, Le Moal M, Simonnet G. 1993. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 14:919-924. (Pubitemid 23297696)
31. Panula P, Aarnisalo AA, Wasowicz K, Neuropeptide FF. 1996. A mammalian neuropeptide with multiple functions. Prog Neurobiol 48:461-487.
32. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
33. Perry SJ, Yi-Kung Huang E, Cronk D, Bagust J, Sharma R, Walker RJ, Wilson S, Burke JF. 1997. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409:426-430.
34. Quelven I, Roussin A, Burlet-Schiltz O, Gouarderes C, Tafani JA, Mazarguil H, Zajac JM. 2002. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Eur J Pharmacol 449:91-98.
35. Quelven I, Roussin A, Zajac JM. 2004. Functional consequences of neuropeptide FF receptors stimulation in mouse: A cerebral glucose uptake study. Neuroscience 126:441-449.
36. Roumy M, Zajac JM. 1998. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345:1-11.
37. Roumy M, Zajac JM. 1999. Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain Res 845:208-214. (Pubitemid 29486460)
38. Roussin A, Serre F, Gouarderes C, Mazarguil H, Roumy M, Mollereau C, Zajac JM. 2005. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem Biophys Res Commun 336:197-203.
39. Samson WK, Keown C, Samson CK, Samson HW, Lane B, Baker JR, Taylor MM. 2003. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Endocrine 20:59-66.
40. Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, Matifas A, Mollereau C, Laurent P, Parmentier M, Kieffer BL, Bourguignon JJ, Simonnet G. 2006. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA 103:466-471.
41. Tolliver BK, Sganga MW, Sharp FR. 2000. Suppression of c-fos induction in the nucleus accumbens prevents acquisition but not expression of morphine-conditioned place preference. Eur J Neurosci 12:3399-3406.
42. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P, Ziff E. 1999. Gene for pain modulatory neuropeptide NPFF: Induction in spinal cord by noxious stimuli. Mol Pharmacol 55:804-811.
43. Yang HY, Fratta W, Majane EA, Costa E. 1985. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82:7757-7761.
44. Yang HY, Tao T, Iadarola MJ. 2008. Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides 42:1-18. (Pubitemid 351187791)